Acute myeloid leukemia (<scp>AML)</scp>‐derived mesenchymal stem cells induce chemoresistance and epithelial–mesenchymal transition‐like program in <scp>AML</scp> through <scp>IL</scp>‐6/<scp>JAK2</scp>/<scp>STAT3</scp> signaling

Jianle Lu(Lanzhou University), Li Zhao(First Hospital of Lanzhou University), Youfan Feng(Lanzhou University), Qiaomei Dong(First Hospital of Lanzhou University), Jincai Yang(First Hospital of Lanzhou University), Shuling Zhang(Fourth People’s Hospital of Jinan)
Cancer Science
June 4, 2023
10.1111/cas.15855
Cited by 46

Related Papers

Inhibition of tumor necrosis factor-α enhances apoptosis induced by nuclear factor-κB inhibition in leukemia cells
|Oncology Letters|2015|16
PLCB4 upregulation is associated with unfavorable prognosis in pediatric acute myeloid leukemia
|Oncology Letters|2019|13
Rhein exerts anti-multidrug resistance in acute myeloid leukemia via targeting FTO to inhibit AKT/mTOR
|Anti-Cancer Drugs|2024|10
The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemia
|Journal of Cancer Research and Clinical Oncology|2023|6
Chemopreventive effect of tomentosin against 7,12-dimethylbenz[a] anthracene-induced breast cancer progression and inhibits the cell proliferation in MCF-7 cells via downregulation of PI3K/AKT signaling pathway
|Pharmacognosy Magazine|2021|2